# Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis

> **NCT00221000** · PHASE2 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 86 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methoxsalen
- **PROCEDURE:** Extracorporeal Photopheresis

## Key facts

- **NCT ID:** NCT00221000
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-10
- **Final completion:** 2006-11
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221000, "Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00221000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*